Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine Foss

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Expert Review of Anticancer Therapy|January 15, 2024
Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphomaAmrita Goyal, Francine Foss
Cancer Treatment and Research|January 1, 2019
Hepatosplenic T-Cell LymphomasLohith Gowda, Francine Foss
Expert Review of Anticancer Therapy|February 8, 2021
New nonchemotherapy treatment options for cutaneous T-cell lymphomasSuzanne Xu, Francine Foss
The Yale Journal of Biology and Medicine|October 18, 2007
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemiaJaehyuk Choi, Francine Foss
Cancer Treatment and Research|September 26, 2009
Reduced-intensity and nonmyeloablative conditioning regimensFrancine Foss, Koen van Besien
Expert Opinion on Drug Safety|February 7, 2022
Safety considerations with the current treatments for peripheral T-cell lymphomaTarsheen Sethi, Francesca Montanari, Francine Foss
Biochemical Pharmacology|May 7, 2002
Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cellsAlexander Urbano, Gullu Gorgun, Francine Foss
Bone Marrow Transplantation|October 18, 2023
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysisAmrita Goyal, Daniel O'Leary, Francine Foss
Future Oncology (London, England)|December 21, 2012
Pralatrexate: treatment of T-cell non-Hodgkin's lymphomaTerri Parker, Lisa Barbarotta, Francine Foss
Clinical Lymphoma|July 2, 2005
Activity of gallium nitrate in refractory peripheral T-cell lymphomaZuoMing Huang, Beth Higgins, Francine Foss
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Expert Review of Anticancer Therapy|January 15, 2024
Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphomaAmrita Goyal, Francine Foss
Cancer Treatment and Research|January 1, 2019
Hepatosplenic T-Cell LymphomasLohith Gowda, Francine Foss
Expert Review of Anticancer Therapy|February 8, 2021
New nonchemotherapy treatment options for cutaneous T-cell lymphomasSuzanne Xu, Francine Foss
The Yale Journal of Biology and Medicine|October 18, 2007
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemiaJaehyuk Choi, Francine Foss
Cancer Treatment and Research|September 26, 2009
Reduced-intensity and nonmyeloablative conditioning regimensFrancine Foss, Koen van Besien
Expert Opinion on Drug Safety|February 7, 2022
Safety considerations with the current treatments for peripheral T-cell lymphomaTarsheen Sethi, Francesca Montanari, Francine Foss
Biochemical Pharmacology|May 7, 2002
Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cellsAlexander Urbano, Gullu Gorgun, Francine Foss
Bone Marrow Transplantation|October 18, 2023
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysisAmrita Goyal, Daniel O'Leary, Francine Foss
Future Oncology (London, England)|December 21, 2012
Pralatrexate: treatment of T-cell non-Hodgkin's lymphomaTerri Parker, Lisa Barbarotta, Francine Foss
Clinical Lymphoma|July 2, 2005
Activity of gallium nitrate in refractory peripheral T-cell lymphomaZuoMing Huang, Beth Higgins, Francine Foss
Pageof 12